The Braverman test is a brain chemistry assessment designed to determine an individual's dominant neurotransmitter type. Developed by Dr. Eric Braverman, the test evaluates four neurotransmitter types: dopamine, acetylcholine, GABA, and serotonin.
The test is a simple questionnaire that assesses different aspects of an individual's behavior, such as their eating habits, sleep patterns, personality traits, and cognitive functioning. Based on the responses, a dominant neurotransmitter type is identified, and a recommended plan is provided to help balance brain chemistry.
The Braverman test is often used to help individuals optimize their brain function and improve their overall health and well-being. It can also be useful for identifying underlying imbalances that may contribute to various health conditions, such as depression, anxiety, ADHD, and addiction.
コメント